PfSPZ-LARC2

N/A

Report date: 2025/03/20 09:22:17

Base Information

Drug NamePfSPZ-LARC2
Drug Alias Namethird-generation PfSPZ vaccine (Sanaria/Seattle Children’s Research Institute/University of Washington)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyBurkina Faso
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeattle Children'S Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesSeattle Children'S Research InstituteSanaria IncUniversity Of Washington
Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A